Jan 8 (Reuters) -
* ASCENTAGE PHARMA ANNOUNCES ACCEPTANCE OF IND APPLICATION BY CHINA FDA FOR CLINICAL STUDY OF NOVEL IAP INHIBITOR TO TREAT HEPATITIS B INFECTION Source text for Eikon:
 